Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ablynx

Request full access

Proprietary therapeutic proteins for treating life-threatening diseases

Ghent, BelgiumFounded 2001Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2007

Ablynx in the Ghent ecosystem

Live from Dealroom

The Ablynx office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later8 investors entered at this stage

  • Flanders Institute for Biotechnology
  • Alta Partners
  • KBC
  • KBC
  • Vrije Universiteit Brussel
  • SR One
  • Alta Ventures
  • Abingworth
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$5.8B

3,641 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Ablynx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.